Status:
COMPLETED
Evaluating Methods to Increase HIV Testing, Access to HIV Care, and HIV Prevention Strategies
Lead Sponsor:
HIV Prevention Trials Network
Collaborating Sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
HIV Infection
Eligibility:
All Genders
Phase:
NA
Brief Summary
This is a five-part study that will take place in the Bronx, New York (NY), and Washington, District of Columbia (DC). The different components of the study will focus on increasing the number of peop...
Detailed Description
The five components of the study include the following: Expanded HIV Testing: The purpose of this part of the study is to increase the number of people being tested for HIV. In select study sites in ...
Eligibility Criteria
Inclusion
- Inclusion/Exclusion Criteria for Linkage-to-Care Component:
- The Linkage-to-Care component of the study will include all individuals ages 12 and older who are permitted to consent, or can be consented for HIV care by a parent/legal guardian according to New York State or Washington, D.C. law, and who are newly found to be HIV-positive at HIV test sites participating in the study. This study component will also include individuals who have been previously diagnosed with HIV but have been out of care for at least a year and are reconfirmed for HIV infection by standard laboratory tests
- Inclusion/Exclusion Criteria for Viral Suppression Component:
- The study population for the viral suppression component of the study will include all individuals ages 12 and older who are permitted to consent, or can be consented for HIV care by a parent/legal guardian according to New York State or Washington, D.C. law, who have initiated care at participating HIV care sites.
- Inclusion Criteria for Prevention for Positives Component:
- All people who are permitted to consent for HIV care according to New York State or Washington, D.C. law
- Receiving care at the selected HIV care sites in the Bronx or Washington, D.C.
- Have attended the clinic one or more times in the 7 months before study entry
- Able to understand either spoken English or Spanish
- Able and willing to provide informed consent
- Participants enrolled into the Prevention for Positives component of the study will participate in the Patient Survey Component
- Exclusion Criteria for Prevention for Positives Component:
- Not seen in the clinic in the 7 months before study entry
- History or evidence of altered mentation, inebriation, or substance use that would interfere with participation in the study
- Unable or unwilling to provide informed consent
- Participation in another study focusing on HIV prevention for positives
Exclusion
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
18442 Patients enrolled
Trial Details
Trial ID
NCT01152918
Start Date
September 1 2010
End Date
December 1 2014
Last Update
April 1 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
DC clinics
Washington D.C., District of Columbia, United States, 20007
2
Bronx clinics
New York, New York, United States, 10453